CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES

Vaccination remains the most effective method of control of spread of a whole range of infections of both viral and bacterial nature. Many bacterial pathogens (Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae) carry polysaccharide capsule on the surface, that is one of the...

Full description

Bibliographic Details
Main Authors: A. V Kolesnikov, A. V Kozyr, I. G Schemyakin, I. A Dyatlov
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2015-06-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.crie.ru/jour/article/view/14094
_version_ 1797782180666015744
author A. V Kolesnikov
A. V Kozyr
I. G Schemyakin
I. A Dyatlov
author_facet A. V Kolesnikov
A. V Kozyr
I. G Schemyakin
I. A Dyatlov
author_sort A. V Kolesnikov
collection DOAJ
description Vaccination remains the most effective method of control of spread of a whole range of infections of both viral and bacterial nature. Many bacterial pathogens (Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae) carry polysaccharide capsule on the surface, that is one of the elements of protection from host organism immune system. At the same time, vaccination with bacteria exopolysaccharides (EPS) ensures infection neutralization. Effectiveness of such vaccine prophylaxis is limited by age of the vaccinated, intensity and duration of the immunity, development of secondary immune response. EPS conjugation with protein antigens was known for a long time to ensure activation of T-cell immunity against EPS and formation of secondary immune response. However, detailed studies of mechanism of immunity modulation by a protein partner as part of a glycoconjugate has not been carried out. T-lymphocyte activation was traditionally thought to occur exclusively due to peptide presentation, that are products of processing of protein component of the conjugate. Recently, information, accumulated in the field of natural carbohydrate, glycolipid and glycoprotein antigen presentation to T-cells, has generated interest in studying mechanisms of cell immunity activation by conjugated vaccines. Progress in this field, as well as development of novel chemical and biochemical, including combinative technologies of synthesis and study of these molecules, opens new opportunities for detailed understanding of mechanism of action for conjugated vaccines and creation of glycoconjugates with increased effectiveness of protective action.
first_indexed 2024-03-13T00:07:22Z
format Article
id doaj.art-07a0b3bb17ed44afaadc2298654c5c1c
institution Directory Open Access Journal
issn 0372-9311
2686-7613
language Russian
last_indexed 2024-03-13T00:07:22Z
publishDate 2015-06-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj.art-07a0b3bb17ed44afaadc2298654c5c1c2023-07-12T20:20:08ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132015-06-01923971062519CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINESA. V Kolesnikov0A. V Kozyr1I. G Schemyakin2I. A Dyatlov3State Scientific Centre of Applied Microbiology and Biotechnology, Research Institute of Engineering ImmunologyState Scientific Centre of Applied Microbiology and BiotechnologyState Scientific Centre of Applied Microbiology and BiotechnologyState Scientific Centre of Applied Microbiology and BiotechnologyVaccination remains the most effective method of control of spread of a whole range of infections of both viral and bacterial nature. Many bacterial pathogens (Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae) carry polysaccharide capsule on the surface, that is one of the elements of protection from host organism immune system. At the same time, vaccination with bacteria exopolysaccharides (EPS) ensures infection neutralization. Effectiveness of such vaccine prophylaxis is limited by age of the vaccinated, intensity and duration of the immunity, development of secondary immune response. EPS conjugation with protein antigens was known for a long time to ensure activation of T-cell immunity against EPS and formation of secondary immune response. However, detailed studies of mechanism of immunity modulation by a protein partner as part of a glycoconjugate has not been carried out. T-lymphocyte activation was traditionally thought to occur exclusively due to peptide presentation, that are products of processing of protein component of the conjugate. Recently, information, accumulated in the field of natural carbohydrate, glycolipid and glycoprotein antigen presentation to T-cells, has generated interest in studying mechanisms of cell immunity activation by conjugated vaccines. Progress in this field, as well as development of novel chemical and biochemical, including combinative technologies of synthesis and study of these molecules, opens new opportunities for detailed understanding of mechanism of action for conjugated vaccines and creation of glycoconjugates with increased effectiveness of protective action.https://microbiol.crie.ru/jour/article/view/14094vaccinesglycoconjugatesbacterial lipopolysaccharidet-cells
spellingShingle A. V Kolesnikov
A. V Kozyr
I. G Schemyakin
I. A Dyatlov
CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
Журнал микробиологии, эпидемиологии и иммунобиологии
vaccines
glycoconjugates
bacterial lipopolysaccharide
t-cells
title CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
title_full CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
title_fullStr CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
title_full_unstemmed CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
title_short CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHANISM BY CONJUGATED POLYSACCHARIDE VACCINES
title_sort contemporary conception of immune response activation mechanism by conjugated polysaccharide vaccines
topic vaccines
glycoconjugates
bacterial lipopolysaccharide
t-cells
url https://microbiol.crie.ru/jour/article/view/14094
work_keys_str_mv AT avkolesnikov contemporaryconceptionofimmuneresponseactivationmechanismbyconjugatedpolysaccharidevaccines
AT avkozyr contemporaryconceptionofimmuneresponseactivationmechanismbyconjugatedpolysaccharidevaccines
AT igschemyakin contemporaryconceptionofimmuneresponseactivationmechanismbyconjugatedpolysaccharidevaccines
AT iadyatlov contemporaryconceptionofimmuneresponseactivationmechanismbyconjugatedpolysaccharidevaccines